drugset / Trial / NCT00697788
Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients
NaSingle-groupOpen-labelTreatment
Summary
Dexmedetomidine is a sedative drug approved for adult patients, intubated, in intensive care units. We are studying whether this drug is cardiovascularly safe in pediatric patients who have recently been burned.
Timeline
- Start
- 2007-07-16
- Primary completion
- 2008-12-30
- Completion
- 2008-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1.3 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1.6 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1.9 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 2.2 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 2.5 ug/kg | — |
Indications
No indication recorded.